1. Home
  2. BLMN vs MLTX Comparison

BLMN vs MLTX Comparison

Compare BLMN & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLMN
  • MLTX
  • Stock Information
  • Founded
  • BLMN 1988
  • MLTX 2021
  • Country
  • BLMN United States
  • MLTX Switzerland
  • Employees
  • BLMN N/A
  • MLTX N/A
  • Industry
  • BLMN Restaurants
  • MLTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BLMN Consumer Discretionary
  • MLTX Health Care
  • Exchange
  • BLMN Nasdaq
  • MLTX Nasdaq
  • Market Cap
  • BLMN 625.3M
  • MLTX 535.3M
  • IPO Year
  • BLMN 2012
  • MLTX N/A
  • Fundamental
  • Price
  • BLMN $7.57
  • MLTX $9.10
  • Analyst Decision
  • BLMN Hold
  • MLTX Buy
  • Analyst Count
  • BLMN 9
  • MLTX 9
  • Target Price
  • BLMN $9.25
  • MLTX $37.63
  • AVG Volume (30 Days)
  • BLMN 2.1M
  • MLTX 10.0M
  • Earning Date
  • BLMN 11-07-2025
  • MLTX 11-06-2025
  • Dividend Yield
  • BLMN 7.96%
  • MLTX N/A
  • EPS Growth
  • BLMN N/A
  • MLTX N/A
  • EPS
  • BLMN N/A
  • MLTX N/A
  • Revenue
  • BLMN $3,933,993,000.00
  • MLTX N/A
  • Revenue This Year
  • BLMN $1.43
  • MLTX N/A
  • Revenue Next Year
  • BLMN $1.47
  • MLTX N/A
  • P/E Ratio
  • BLMN N/A
  • MLTX N/A
  • Revenue Growth
  • BLMN 2.47
  • MLTX N/A
  • 52 Week Low
  • BLMN $6.09
  • MLTX $5.95
  • 52 Week High
  • BLMN $17.57
  • MLTX $62.75
  • Technical
  • Relative Strength Index (RSI)
  • BLMN 57.74
  • MLTX 23.15
  • Support Level
  • BLMN $7.18
  • MLTX $8.18
  • Resistance Level
  • BLMN $7.56
  • MLTX $9.54
  • Average True Range (ATR)
  • BLMN 0.28
  • MLTX 2.00
  • MACD
  • BLMN 0.10
  • MLTX -3.65
  • Stochastic Oscillator
  • BLMN 95.72
  • MLTX 5.47

About BLMN Bloomin' Brands Inc.

Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabbas. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S. while restaurants operating outside the U.S. are included in the international segment.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

Share on Social Networks: